Muscarinic antagonist

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Antimuscarinic)
Jump to: navigation, search

WikiDoc Resources for

Muscarinic antagonist

Articles

Most recent articles on Muscarinic antagonist

Most cited articles on Muscarinic antagonist

Review articles on Muscarinic antagonist

Articles on Muscarinic antagonist in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Muscarinic antagonist

Images of Muscarinic antagonist

Photos of Muscarinic antagonist

Podcasts & MP3s on Muscarinic antagonist

Videos on Muscarinic antagonist

Evidence Based Medicine

Cochrane Collaboration on Muscarinic antagonist

Bandolier on Muscarinic antagonist

TRIP on Muscarinic antagonist

Clinical Trials

Ongoing Trials on Muscarinic antagonist at Clinical Trials.gov

Trial results on Muscarinic antagonist

Clinical Trials on Muscarinic antagonist at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Muscarinic antagonist

NICE Guidance on Muscarinic antagonist

NHS PRODIGY Guidance

FDA on Muscarinic antagonist

CDC on Muscarinic antagonist

Books

Books on Muscarinic antagonist

News

Muscarinic antagonist in the news

Be alerted to news on Muscarinic antagonist

News trends on Muscarinic antagonist

Commentary

Blogs on Muscarinic antagonist

Definitions

Definitions of Muscarinic antagonist

Patient Resources / Community

Patient resources on Muscarinic antagonist

Discussion groups on Muscarinic antagonist

Patient Handouts on Muscarinic antagonist

Directions to Hospitals Treating Muscarinic antagonist

Risk calculators and risk factors for Muscarinic antagonist

Healthcare Provider Resources

Symptoms of Muscarinic antagonist

Causes & Risk Factors for Muscarinic antagonist

Diagnostic studies for Muscarinic antagonist

Treatment of Muscarinic antagonist

Continuing Medical Education (CME)

CME Programs on Muscarinic antagonist

International

Muscarinic antagonist en Espanol

Muscarinic antagonist en Francais

Business

Muscarinic antagonist in the Marketplace

Patents on Muscarinic antagonist

Experimental / Informatics

List of terms related to Muscarinic antagonist

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

A muscarinic receptor antagonist is an agent that reduces the activity of the muscarinic acetylcholine receptor. Most of them are synthetic, but scopolamine atropine are belladonna alkaloids, and are naturally extracted.

Important[1] muscarinic agonists include atropine, hyoscine, ipratropium, tropicamide, cyclopentolate and pirenzepine.

Comparison table

Substance Trade names Mechanism[2] Clinical use[2] Adverse effects[2]
Atropine (D/L-Hyoscyamine) non-selective antagonism, CNS stimulation
Scopolamine (L-Hyoscine) non-selective antagonism, CNS depression
Ipratropium non-selective antagonism, without any mucociliary excretion inhibition.
Tropicamide short acting non-selective antagonism, CNS depression
Pirenzepine M1 receptor-selective antagonist (fewer than non-selective ones)
Diphenhydramine Benadryl
Dimenhydrinate Dramamine
dicyclomine
flavoxate
oxybutynin
tiotropium Spiriva
cyclopentolate short acting non-selective antagonism, CNS depression
atropine methonitrate non-selective antagonism, blocks transmission in ganglia
trihexyphenidyl Artane
tolterodine Detrusitol
solifenacin Vesicare
darifenacin Enablex
benztropine Cogentin

See also

References

  1. Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 147
  2. 2.0 2.1 2.2 Unless else specified in table boxes, then ref is: Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 147

External links


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .